Search Results - "Annese, V."

Refine Results
  1. 1
  2. 2

    Review article: the natural history of paediatric‐onset ulcerative colitis in population‐based studies by Fumery, M., Duricova, D., Gower‐Rousseau, C., Annese, V., Peyrin‐Biroulet, L., Lakatos, P. L.

    Published in Alimentary pharmacology & therapeutics (01-02-2016)
    “…Summary Background A better knowledge of the natural history of disabling chronic diseases is essential to improve patient management, evaluate the impact of…”
    Get full text
    Journal Article
  3. 3

    Multidrug resistance 1 gene in inflammatory bowel disease: A meta-analysis by Annese, V, Valvano, M-R, Palmieri, O, Latiano, A, Bossa, F, Andriulli, A

    Published in World journal of gastroenterology : WJG (21-06-2006)
    “…The MDR1 gene is an attractive candidate gene for the pathogenesis of inflammatory bowel disease (IBD) and perhaps response to therapy, with evidences at both…”
    Get full text
    Journal Article
  4. 4

    Micromolar Metabolite Measurement in an Electronically Multiplexed Format by Annese, V. F., Giagkoulovits, C., Hu, C., Al-Rawhani, M. A., Grant, J., Patil, S. B., Cumming, D. R. S.

    “…Objective : The detection of metabolites such as choline in blood are important in clinical care for patients with cancer and cardiovascular disease. Choline…”
    Get full text
    Journal Article
  5. 5
  6. 6

    IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease by Barcia, C, Ros, C M, Annese, V, Gómez, A, Ros-Bernal, F, Aguado-Llera, D, Martínez-Pagán, M E, de Pablos, V, Fernandez-Villalba, E, Herrero, M T

    Published in Cell death & disease (07-04-2011)
    “…To through light on the mechanisms underlying the stimulation and persistence of glial cell activation in Parkinsonism, we investigate the function of IFN- γ…”
    Get full text
    Journal Article
  7. 7

    Circulating T cells to infliximab are detectable mainly in treated patients developing anti‐drug antibodies and hypersensitivity reactions by Vultaggio, A., Petroni, G., Pratesi, S., Nencini, F., Cammelli, D., Milla, M., Prignano, F., Annese, V., Romagnani, S., Maggi, E., Matucci, A.

    Published in Clinical and experimental immunology (01-12-2016)
    “…Summary Antibodies recognizing infliximab (IFX) may develop in a proportion of treated patients, leading to loss of response or hypersensitivity reactions…”
    Get full text
    Journal Article
  8. 8

    Infliximab in severe ulcerative colitis: short‐term results of different infusion regimens and long‐term follow‐up by KOHN, A., DAPERNO, M., ARMUZZI, A., CAPPELLO, M., BIANCONE, L., ORLANDO, A., VISCIDO, A., ANNESE, V., RIEGLER, G., MEUCCI, G., MARROLLO, M., SOSTEGNI, R., GASBARRINI, A., PERALTA, S., PRANTERA, C.

    Published in Alimentary Pharmacology and Therapeutics (01-09-2007)
    “…Summary Background Severe ulcerative colitis is a life‐threatening disorder, despite i.v. glucocorticoids treatment. Infliximab has been proposed as a safe…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Randomised clinical trial: low-volume bowel preparation for colonoscopy - a comparison between two different PEG-based formulations by Repici, A., Cestari, R., Annese, V., Biscaglia, G., Vitetta, E., Minelli, L., Trallori, G., Orselli, S., Andriulli, A., Hassan, C.

    Published in Alimentary pharmacology & therapeutics (01-10-2012)
    “…Summary Background Low‐volume bowel preparations with polyethylene glycol (PEG) have been shown to provide an equivalent cleansing with improved tolerability…”
    Get full text
    Journal Article
  11. 11

    Genetic variants in the region harbouring IL2/IL21 associated with ulcerative colitis by Festen, E A M, Goyette, P, Scott, R, Annese, V, Zhernakova, A, Lian, J, Lefèbvre, C, Brant, S R, Cho, J H, Silverberg, M S, Taylor, K D, de Jong, D J, Stokkers, P C, Mcgovern, D, Palmieri, O, Achkar, J-P, Xavier, R J, Daly, M J, Duerr, R H, Wijmenga, C, Weersma, R K, Rioux, J D

    Published in Gut (01-06-2009)
    “…Genetic susceptibility is known to play a large part in the predisposition to the inflammatory bowel diseases (IBDs) known as Crohn's disease (CD) and…”
    Get more information
    Journal Article
  12. 12

    A digital processor architecture for combined EEG/EMG falling risk prediction by Annese, V. F., Crepaldi, M., Demarchi, D., De Venuto, D.

    “…The brain signal anticipates the voluntary movement with patterns that can be detected even 500ms before the occurrence. This paper presents a digital signal…”
    Get full text
    Conference Proceeding Journal Article
  13. 13

    Polymorphism of the IRGM Gene Might Predispose to Fistulizing Behavior in Crohn's Disease by LATIANO, A, PALMIERI, O, ANNESE, V, CUCCHIARA, S, CASTRO, M, D'INCA, R, GUARISO, G, DALLAPICCOLA, B, VALVANO, M. R, LATIANO, T, ANDRIULLI, A

    Published in The American journal of gastroenterology (01-01-2009)
    “…Recently, genome-wide association analyses have identified single nucleotide polymorphisms in the IRGM gene (rs1000113 and rs4958847) as strong candidate…”
    Get full text
    Journal Article
  14. 14
  15. 15

    IFN-γ signaling, with the synergistic contribution of TNF-α, mediates cell specific microglial and astroglial activation in experimental models of Parkinson's disease by Barcia, C, Ros, C M, Annese, V, Gómez, A, Ros-Bernal, F, Aguado-Llera, D, Martínez-Pagán, M E, de Pablos, V, Fernandez-Villalba, E, Herrero, M T

    Published in Cell death & disease (01-08-2012)
    “…To through light on the mechanisms underlying the stimulation and persistence of glial cell activation in Parkinsonism, we investigate the function of IFN-γ…”
    Get full text
    Journal Article
  16. 16

    Usefulness of omega-3 fatty acid supplementation in addition to mesalazine in maintaining remission in pediatric Crohn's disease: a double-blind, randomized, placebo-controlled study by Romano, C, Cucchiara, S, Barabino, A, Annese, V, Sferlazzas, C

    Published in World journal of gastroenterology : WJG (07-12-2005)
    “…To assess the value of long-chain omega-3 fatty acids (FAs) supplementation in addition to amino-salicylic-acid (5-ASA) in pediatric patients with Crohn's…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Glucocorticoid resistance in Crohn's disease and ulcerative colitis: an association study investigating GR and FKBP5 gene polymorphisms by Maltese, P, Palma, L, Sfara, C, de Rocco, P, Latiano, A, Palmieri, O, Corritore, G, Annese, V, Magnani, M

    Published in The pharmacogenomics journal (01-10-2012)
    “…The aim of this study is to investigate the role of single-nucleotide polymorphisms (SNPs) of the glucocorticoid receptor ( GR ) and of the related…”
    Get full text
    Journal Article
  19. 19

    Topical butyrate improves efficacy of 5-ASA in refractory distal ulcerative colitis: results of a multicentre trial by Vernia, P., Annese, V., Bresci, G., D'Albasio, G., D'Incà, R., Giaccari, S., Ingrosso, M., Mansi, C., Riegler, G., Valpiani, D., Caprilli, R.

    Published in European journal of clinical investigation (01-03-2003)
    “…Background The treatment of distal ulcerative colitis, refractory to conventional 5‐ASA/steroid treatment, is still a matter of debate. The present study aimed…”
    Get full text
    Journal Article
  20. 20